<DOC>
	<DOC>NCT00693316</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of escalating doses of ORM-12741 in healthy volunteers.</brief_summary>
	<brief_title>Safety and Tolerability Study With Single Ascending Doses of ORM-12741</brief_title>
	<detailed_description />
	<criteria>Good general health ascertained by detailed medical history and physical examinations Males between 18 and 45 years Body mass index (BMI) between 1830 kg/m2 Weight 5590 kg Evidence of clinically significant cardiovascular, renal, hepatic, haematological, gastrointestinal, pulmonary, metabolicendocrine, neurological, urogenital or psychiatric disease Any condition requiring regular concomitant treatment including herbal products or likely to need any concomitant treatment during the study Susceptibility to severe allergic reactions Regular consumption of more than 14 units of alcohol per week Current use of nicotinecontaining products more than 5 cigarettes or equivalent/day Inability to refrain from using nicotinecontaining products during the stay in the study centre Inability to refrain from consuming caffeinecontaining beverages during the stay in the study centre Blood donation or loss of significant amount of blood within 3 months prior to the screening visit Abnormal finding in ECG, vital signs, laboratory tests or physical examination Participation in a drug study within 3 months prior to the start of this study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Healthy volunteer study</keyword>
</DOC>